Theragenics
This article was originally published in The Gray Sheet
Executive Summary
Radiation therapy device manufacturer receives IDE for the TheraP trial, which will test the TheraSource intravascular brachytherapy system for prevention of restenosis following balloon angioplasty of long, diffuse lesions in the superficial femoral and popliteal arteries. The study will enroll 30 patients at up to three sites...